Sensory nerves are frequently involved in the spectrum of fisher syndrome

Muscle and Nerve

Volumn 49, Issue 4, 2014, Pages 558-563

  Shahrizaila, Nortina ^a   Goh, Khean J ^a   Kokubun, Norito ^b   Tan, Ai H ^a   Tan, Cheng Y ^a   Yuki, Nobuhiro ^c  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b DOKKYO MEDICAL UNIVERSITY   (Japan)

^c Dept Medicine Endocrinol Diabet   (Singapore)

Author keywords

Anti ganglioside antibody; Fisher syndrome; Guillain Barr syndrome; Nerve conduction study; Sensory neuropathy

Indexed keywords

GANGLIOSIDE; IMMUNOGLOBULIN G;

ACTION POTENTIAL; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; MALE; MIDDLE AGED; MOTOR NERVE; NERVE CONDUCTION; NERVE FIBER; NERVE REGENERATION; NEUROLOGIC EXAMINATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSORY NERVE; VERY ELDERLY; YOUNG ADULT;

ANTI-GANGLIOSIDE ANTIBODY; FISHER SYNDROME; GUILLAIN-BARRÉ SYNDROME; NERVE CONDUCTION STUDY; SENSORY NEUROPATHY;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; MILLER FISHER SYNDROME; NEURAL CONDUCTION; PROSPECTIVE STUDIES; SENSORY RECEPTOR CELLS; YOUNG ADULT;

EID: 84896119822     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.23973     Document Type: Article

References (36)

1. Guillain G, Barré JA, Strohl A. Sur un syndrome de radiculonévrite avec hyperalbuminose du liquide céphalo-rachidien sans réaction cellulaire. Remarques sur les caractères cliniques et graphiques des réflexes tendineux. Bulletins et mémoires de la Société des Médecins des Hôpitaux de Paris 1916;40:1462-1470.
2. Fisher M. An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia). N Engl J Med 1956;255:57-65.
3. Mori M, Kuwabara S, Fukutake T, Yuki N, Hattori T. Clinical features and prognosis of Miller Fisher syndrome. Neurology 2001;56:1104-1106.
4. Chiba A, Kusunoki S, Shimizu T, Kanazawa I. Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome. Ann Neurol 1992;31:677-679.
5. Shahrizaila N, Yuki N. Bickerstaff brainstem encephalitis and Fisher syndrome: anti-GQ1b antibody syndrome. J Neurol Neurosurg Psychiatry 2013;84:576-583.
6. Fross RD, Daube JR. Neuropathy in the Miller Fisher syndrome: clinical and electrophysiologic findings. Neurology 1987;37:1493-1498.
7. Jamal GA, Ballantyne JP. The localization of the lesion in patients with acute ophthalmoplegia, ataxia and areflexia (Miller Fisher syndrome): a serial multimodal neurophysiological study. Brain 1988;111:95-114.
8. Umapathi T, Tan EY, Kokubun N, Verma K, Yuki N. Non-demyelinating, reversible conduction failure in Fisher syndrome and related disorders. J Neurol Neurosurg Psychiatry 2012;83:941-948.
9. Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol 1990;27(suppl):S21-24.
10. Bickerstaff ER. Brain-stem encephalitis: further observations on a grave syndrome with benign prognosis. BMJ 1957;1:1384-1387.
11. Shahrizaila N, Goh KJ, Abdullah S, Kuppusamy R, Yuki N. Two sets of nerve conduction studies may suffice in reaching a reliable electrodiagnosis in Guillain-Barré syndrome. Clin Neurophysiol 2013;124:1456-1459.
12. Shahrizaila N, Goh KJ, Kokubun N, Abdullah S, Yuki N. Serial nerve conduction studies provide insight into the pathophysiology of Guillain-Barré and Fisher syndromes. J Neurol Sci 2011;309:26-30.
13. Hadden RDM, Cornblath DR, Hughes RAC, Zielasek J, Hartung HP, Toyka KV, et al. Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Ann Neurol 1998;44:780-788.
14. Ho TW, Mishu B, Li CY, Gao CY, Cornblath DR, Griffin JW, et al. Guillain-Barré syndrome in northern China: relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain 1995;118:597-605.
15. Feasby TE, Hahn AF, Brown WF, Bolton CF, Gilbert JJ, Koopman WJ. Severe axonal degeneration in acute Guillain-Barré syndrome: evidence of two different mechanisms? J Neurol Sci 1993;116:185-192.
16. Capasso M, Notturno F, Manzoli C, Uncini A. Involvement of sensory fibres in axonal subtypes of Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 2011;82:664-670.
17. Olney RK. Guidelines in electrodiagnostic medicine: consensus criteria for the diagnosis of partial conduction block. Muscle Nerve 1999;8(suppl):S225-229.
18. Kuwabara S, Yuki N, Koga M, Hattori T, Matsuura D, Miyake M, et al. IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain-Barré syndrome. Ann Neurol 1998;44:202-208.
19. Funakoshi K, Kuwabara S, Odaka M, Hirata K, Yuki N. Clinical predictors of mechanical ventilation in Fisher/Guillain-Barré overlap syndrome. J Neurol Neurosurg Psychiatry 2009;80:60-64.
20. Notturno F, Caporale CM, Uncini A. Acute sensory ataxic neuropathy with antibodies to GD1b and GQ1b gangliosides and prompt recovery. Muscle Nerve 2008;37:265-268.
21. Pan CL, Yuki N, Koga M, Chiang MC, Hsieh ST. Acute sensory ataxic neuropathy associated with monospecific anti-GD1b IgG antibody. Neurology 2001;57:1316-1318.
22. Kaida K, Kamakura K, Ogawa G, Ueda M, Motoyoshi K, Arita M, et al. GD1b-specific antibody induces ataxia in Guillain-Barré syndrome. Neurology 2008;71:196-201.
23. Susuki K, Yuki N, Schafer DP, Hirata K, Zhang G, Funakoshi K, et al. Dysfunction of nodes of Ranvier: a mechanism for anti-ganglioside antibody-mediated neuropathies. Exp Neurol 2012;233:534-542.
24. Capasso M, Notturno F, Manzoli C, Yuki N, Uncini A. Reversible conduction failure in pharyngeal-cervical-brachial variant of Guillain-Barré syndrome. Muscle Nerve 2010;42:608-612.
25. Chiba A, Kusunoki S, Obata H, Machinami R, Kanazawa I. Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies. Neurology 1993;43:1911-1917.
26. Ito M, Kuwabara S, Odaka M, Misawa S, Koga M, Hirata K, et al. Bickerstaff's brainstem encephalitis and Fisher syndrome form a continuous spectrum: clinical analysis of 581 cases. J Neurol 2008;255:674-682.
27. Willison HJ, Veitch J, Paterson G, Kennedy PG. Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside. J Neurol Neurosurg Psychiatry 1993;56:204-206.
28. Kuwahara M, Suzuki S, Takada K, Kusunoki S. Antibodies to LM1 and LM1-containing ganglioside complexes in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy. J Neuroimmunol 2011;239:87-90.
29. Kaida K, Kanzaki M, Morita D, Kamakura K, Motoyoshi K, Hirakawa M, et al. Anti-ganglioside complex antibodies in Miller Fisher syndrome. J Neurol Neurosurg Psychiatry 2006;77:1043-1046.
30. Kanzaki M, Kaida K, Ueda M, Morita D, Hirakawa M, Motoyoshi K, et al. Ganglioside complexes containing GQ1b as targets in Miller Fisher and Guillain-Barré syndromes. J Neurol Neurosurg Psychiatry 2008;79:1148-1152.
31. Koga M, Gilbert M, Takahashi M, Li J, Hirata K, Kanda T, et al. GQ1b-seronegative Fisher syndrome: clinical features and new serological markers. J Neurol 2012;259:1366-1374.
32. Ogawa G, Kaida K, Kusunoki S, Ueda M, Kimura F, Kamakura K. Antibodies to ganglioside complexes consisting of asialo-GM1 and GQ1b or GT1a in Fisher and Guillain-Barré syndromes. J Neuroimmunol 2009;214:125-127.
33. Lyu RK, Tang LM, Cheng SY, Hsu WC, Chen ST. Guillain-Barré syndrome in Taiwan: a clinical study of 167 patients. J Neurol Neurosurg Psychiatry 1997;63:494-500.
34. Ng YS, Lo YL, Lim PA. Characteristics and acute rehabilitation of Guillain-Barré syndrome in Singapore. Ann Acad Med Singapore 2004;33:314-319.
35. Lolekha P, Phanthumchinda K. Miller Fisher syndrome at King Chulalongkorn Memorial Hospital. J Med Assoc Thai 2009;92:471-477.
36. San-Juan OD, Martinez-Herrera JF, Garcia JM, Gonzalez-Aragon MF, Del Castillo-Calcaneo Jde D, et al. Miller Fisher syndrome: 10 years' experience in a third-level center. Eur Neurol 2009;62:149-154.